Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro

Japanese Journal of Cancer Research

Volumn 89, Issue 10, 1998, Pages 1047-1054

  Naoe, Yoshinori ^a   Inami, Masamichi ^a   Takagaki, Shoji ^a   Matsumoto, Sanae ^a   Kawamura, Ikuo ^a   Nishigaki, Fusako ^a   Tsujimoto, Susumu ^a   Manda, Toshitaka ^a   Shimomura, Kyoichi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Antitumor effect; Deacetyl metabolite; FK317; MDR; P glycoprotein

Indexed keywords

1 ACETYL 8 CARBAMOYLOXYMETHYL 3,9 EPOXY 5 FORMYL 1A,2,3,8,9,9A HEXAHYDRO 9 HYDROXY 7 METHOXY 1H AZIRINO[2,3 C][1]BENZAZOCINE ACETATE; ANTINEOPLASTIC AGENT; AZIDOPINE; BENZOXAZINE DERIVATIVE; DOXORUBICIN; GLYCOPROTEIN P; TRITIUM; UNCLASSIFIED DRUG; VERAPAMIL; VINBLASTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG ACETYLATION; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LUNG CARCINOMA; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NUDE MOUSE; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; TUMOR CELL;

EID: 0031785805     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00495.x     Document Type: Article

References (28)

1. Biedler, J. L. Genetic aspects of multidrug resistance. Cancer, 70, 1799-1809 (1992).
2. Safa, A. R. Photoaffinity labeling of P-glycoprotein in multidrug-resistant cells. Cancer Invest., 11, 46-56 (1993).
3. Juliano, R. L. and Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 455, 152-162 (1976).
4. Kartner, N., Riordan, J. R. and Ling, V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science, 221, 1285-1288 (1983).
5. Roninson, I. B., Chin, J. E., Choi, K., Gros, P., Housman, D. E., Fojo, A., Shen, D.-W., Gottesman, M. M. and Pastan, I. Isolation of human mdr DNA sequences amplified in multidrug resistant KB carcinoma cells. Proc. Natl. Acad. Sci. USA, 83, 4538-4542 (1986).
6. Chen, C., Chin, J. E., Ueda, K., Clark, D. R., Pastan, I., Gottesman, M. M. and Roninson, I. B. Internal duplication and homology with bacterial transport protein in the mdr1 (p-glycoprotein) gene from multidrug-resistant human cells. Cell, 47, 381-389 (1986).
7. Gros, P., Croop, J. and Housman, D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell, 47, 371-380 (1986).
8. Gerlach, J. H., Endicott, J. H., Juranka, P. F., Henderson, G., Sarangi, F., Deuchars, K. L. and Ling, V. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature, 324, 485-489 (1986).
9. Hamada, H. and Tsuruo, T. Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance: the 170- to 180-kilodalton membrane glycoprotein is an ATPase. J. Biol. Chem., 263, 1454-1458 (1988).
10. Dano, K. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim. Biophys. Acta, 323, 466-483 (1988).
11. Inaba, M., Kobayashi, H., Sakurai, Y. and Johnson, R. K. Active efflux of daunomycin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res., 39, 2200-2203 (1979).
12. Gros, P., Neriah, Y. B., Croop, J. M. and Housman, D. E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature, 323, 728-731 (1986).
13. Shimomura, K., Manda, T., Mukumoto, S., Masuda, K., Nakamura, T., Mizota, T., Matsumoto, S., Nishigaki, F., Oku, T., Mori, J. and Shibayama, F. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice. Cancer Res., 48, 1166-1172 (1988).
14. Masuda, K., Nakamura, T., Mizota, T., Mori, J. and Shimomura, K. Interstrand DNA-DNA and DNA-protein cross-links by a new antitumor antibiotic, FK973, in L1210 cells. Cancer Res., 48, 5172-5177 (1988).
15. Majima, H., Hasegawa, K., Fukuoku, M., Furuse, K., Wakui, A., Furue, H., Masaoka, T., Hattori, T., Taguchi, T., Ogura, T. and Niitani, H. Phase I clinical and pharmacokinetic study of FK973. Proc. Am. Soc. Clin. Oncol., 9, 78 (1990).
16. Pazdur, R., Ho, D. H., Daugherty, K., Bradner, W. T., Krakoff, I. H. and Raber, M. N. Phase I trial of FK973: description of a delayed vascular leak syndrome. Invest. New Drugs, 9, 337-382 (1991).
17. Naoe, Y., Inami, M., Matsumoto, S., Nishigaki, F., Tsujimoto, S., Kawamura, I., Miyayasu, K., Manda, T. and Shimomura, K. FK317; a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome. Cancer Chemother. Pharmacol., 42, 31-36 (1998).
18. Ueyama, Y. Applications for research on cancer treatment methods using cancer characteristics. In "The Nude Mouse and Anticancer Drug Evaluation," ed. T. Nakamura, Y. Sakurai and M. Inaba, pp.197-203 (1996). Central Institute for Experimental Animals Press, Kawasaki.
19. Shen, D.-W., Cardarelli, C., Hwang, J., Cornwell, M., Richert, N., Ishii, S., Pastan, I. and Gottesman, M. M. Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J. Biol. Chem., 261, 7762-7770 (1986).
20. Kiura, K., Ohnoshi, T., Tabata, M., Shibayama, T. and Kimura, I. Establishment of an adriamycin-resistant subline of human small cell lung cancer showing multifactorial mechanisms of resistance. Acta Med. Okayama, 47, 191-197 (1993).
21. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63 (1983).
22. Sato, W., Fukazawa, N., Suzuki, T., Yusa, K. and Tsuruo, T. Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073. Cancer Res., 51, 2420-2424 (1991).
23. Ambudkar, S. V., Lelong, I. H., Zhang, J., Cardarelli, C. O., Gottesman, M. M. and Pastan, I. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc. Natl. Acad. Sci. USA, 89, 8472-8476 (1992).
24. Lockridge, O., Mottershaw, J. N., Eckerson, H. W. and La Du, B. N. Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase. J. Pharmacol. Exp. Ther., 215, 1-8 (1980).
25. Elbaum, D. and Nagel, R. L. Esterase activity of hemoglobin. J. Biol. Chem., 256, 2280-2283 (1981).
26. Mizuno, K., Furuhashi, Y., Maeda, O., Iwata, M., Misawa, T., Kawai, M., Kano, T. and Tomoda, Y. Mitomycin C cross-resistance induced by adriamycin in human ovarian cancer cell in vitro. Cancer Chemother. Pharmacol., 26, 333-339 (1990).
27. Wakusawa, S., Nakamura, S. and Miyamoto, K. Establishment by adriamycin exposure of multidrug-resistant rat ascites hepatoma AH130 cells showing low DT-diaphorase activity and high cross resistance to mitomycins. Jpn. J. Cancer Res., 88, 88-96 (1997).
28. Zamora, J. M., Pearce, H. L. and Beck, W. T. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol. Pharmacol., 33, 454-462 (1988).